Protagenic Therapeutics, Inc. (PTIX) Stock
PTIX Key Statistics
About Protagenic Therapeutics, Inc.
Protagenic Therapeutics, Inc., a biopharmaceutical company, engages in the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. Its lead compound is PT00114, a synthetic form of teneurin carboxy-terminal associated peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. The company is based in New York, New York.
CEO: Garo H. Armen. Company website
PTIX — Frequently Asked Questions
What is the PTIX stock price today?
Protagenic Therapeutics, Inc. (PTIX) trades at $0.26, up 30.00% on the day, as of Nov 12, 2026 10:46 UTC.
What is Protagenic Therapeutics, Inc.'s market cap?
Protagenic Therapeutics, Inc. has a market capitalisation of $503,068.02, calculated from the live PTIX share price and shares outstanding.
What is the P/E ratio of PTIX?
PTIX has no meaningful price-to-earnings ratio: Protagenic Therapeutics, Inc. lost $3.45 per share over the last twelve months, and a P/E is only defined on positive earnings.
How much revenue does Protagenic Therapeutics, Inc. make?
Protagenic Therapeutics, Inc. generated revenue of $0.00 over the trailing twelve months.
What is the 52-week range for PTIX?
PTIX has traded between $0.17 and $1.20 over the past 52 weeks, and the last price is 78.3% below that high.
Is Protagenic Therapeutics, Inc. profitable?
Yes. Protagenic Therapeutics, Inc. keeps 0.00% of revenue as net income over the trailing twelve months.
What is the analyst price target for PTIX?
Wall Street analysts rate PTIX Buy.
What sector is Protagenic Therapeutics, Inc. in?
Protagenic Therapeutics, Inc. is classified under the Healthcare sector and the Biotechnology industry, and is domiciled in US .
Who is the CEO of Protagenic Therapeutics, Inc.?
Garo H. Armen is the chief executive of Protagenic Therapeutics, Inc., which employs 1 people.
Where can I track PTIX in real time?
QFI Terminal shows PTIX with live charts, full financials, the options chain with gamma exposure, institutional ownership and analyst ratings on one screen. The free plan has no time limit and asks for no card.
See PTIX live in QFI Terminal
Interactive charts, full financials, options chain, gamma exposure, ownership and analyst ratings, all in one institutional-grade terminal.
Open PTIX in Terminal See plans